Feb 21, 2019
Marker Therapeutics Congratulates Helen E. Heslop, MD, DSc (Hon) on Receiving the ASBMT Lifetime Achievement Award
Feb 21, 2019
Actinium Highlights New Data at TCT Meetings Demonstrating Effective Lymphodepletion Supporting Iomab-ACT Program Development for Targeted Conditioning Prior to CAR-T and Adoptive Cell Therapy
Feb 20, 2019
Marker Therapeutics to Present at the CAR-TCR Summit Europe
Feb 19, 2019
Arix Bioscience plc: Autolus Announces Updated Results From CARPALL Trial
Feb 19, 2019
Autolus Therapeutics Announces Updated Results from Ongoing CARPALL Trial of Pediatric Acute Lymphoblastic Leukemia Presented at the EHA 1st European CAR T Cell Meeting in Paris
Feb 07, 2019
Marker Therapeutics Appoints Mythili Koneru, M.D., Ph.D. as Senior Vice President, Clinical Development
Feb 06, 2019
Actinium Provides Patent Portfolio Update for its Iomab-ACT Next-Generation CAR-T Lymphodepletion Program
Jan 29, 2019
CARsgen Therapeutics Receives IND Clearance for GPC3-CAR-T Cells from the NMPA
Jan 28, 2019
UMN Medical School Researchers Discover New Therapy for Prostate Cancer Patients
Jan 24, 2019
Anixa Biosciences CAR-T Cancer Therapy Patent Receives Notice of Allowance
Jan 23, 2019
B-MoGen Biotechnologies and CytoSen Therapeutics partner on research collaboration to develop next generation Natural Killer Cells for human therapeutics
Jan 17, 2019
TrakCel and Quick partner to provide industry-leading digital supply chain IT solution for cell and gene therapies
Jan 17, 2019
Chimeric Antigen Receptor (CAR) T Cell Immunotherapy - Journey From Target to T Cell Product: A Platform to Identify Opportunities and Overcome Challenges, 2018 by DelveInsight
Jan 17, 2019
Marker Therapeutics to Present at the Phacilitate Leaders World & World Stem Cell Summit 2019
Jan 16, 2019
Actinium Pharmaceuticals Appoints Qing Liang, PhD, DABR as Vice President, Head of Radiation Sciences to Further Innovation for its AWE Technology Platform and Growing Pipeline of Antibody Radiation Conjugate Therapies
Jan 15, 2019
The Center for Cell and Gene Therapy at Baylor College of Medicine to Present at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR 2019
Jan 08, 2019
Cellular Biomedicine Group Initiates Patient Recruitment for Clinical Trial in B Cell Maturation Antigen (Anti-BCMA) Chimeric Antigen Receptor T-Cell (CAR-T) Therapy Targeting Multiple Myeloma (MM)
Jan 07, 2019
FloDesign Sonics announces ekko(TM), a platform technology for cell and gene therapy manufacturing at the Biotech Showcase(TM) in San Francisco.
Dec 18, 2018
Global engineered t cells market is expected to grow with a healthy CAGR over the forecast period from 2018-2024
Dec 06, 2018
Marker Therapeutics to Present at the Tumor Targeted Lymphocytes Summit